Company Overview
- Headquarters
- 700 Technology Square, 2nd Floor, Cambridge MA
- Website
- tiburio.com
- Phone
- (617) 231-6050
- Employees
- 3
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is Tiburio Therapeutics
Tiburio Therapeutics is a clinical stage biopharmaceutical company located in Cambridge, Massachusetts. Founded with three employees, the company focuses on developing innovative treatments for rare neuroendocrine tumors and endocrine diseases. Tiburio's portfolio includes two clinical stage compounds: TBR-760, designed for the treatment of non-functioning pituitary adenoma (NFPA), and TBR-065, intended for various other rare endocrine diseases. Their research and development efforts target areas where existing treatments are limited, aiming to address significant unmet patient needs. Leveraging expertise from the orphan drug accelerator Cydan, Tiburio Therapeutics benefits from substantial funding from prominent life sciences investors. This financial backing supports the company's mission to advance promising therapies for patients facing challenging rare diseases. Interested parties can learn more about Tiburio Therapeutics and its innovative approach to treatment by visiting their website at tiburio.com.
Company Leadership
Companies Similar to Tiburio Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Tiburio Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |